Morgan Stanley’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Buy |
1,097,651
+3,693
| +0.3% | +$4.28K | ﹤0.01% | 4985 |
|
|
2025
Q1 | $1.74M | Sell |
1,093,958
-619,230
| -36% | -$985K | ﹤0.01% | 4693 |
|
|
2024
Q4 | $5.19M | Buy |
1,713,188
+101,621
| +6% | +$308K | ﹤0.01% | 3963 |
|
|
2024
Q3 | $5.93M | Sell |
1,611,567
-339,155
| -17% | -$1.25M | ﹤0.01% | 3840 |
|
|
2024
Q2 | $7.98M | Buy |
1,950,722
+913,313
| +88% | +$3.74M | ﹤0.01% | 3492 |
|
|
2024
Q1 | $16.3M | Sell |
1,037,409
-181,557
| -15% | -$2.86M | ﹤0.01% | 2913 |
|
|
2023
Q4 | $18.5M | Buy |
1,218,966
+673,346
| +123% | +$10.2M | ﹤0.01% | 3418 |
|
|
2023
Q3 | $10.9M | Buy |
545,620
+42,745
| +9% | +$857K | ﹤0.01% | 3043 |
|
|
2023
Q2 | $14.2M | Buy |
502,875
+231,611
| +85% | +$6.53M | ﹤0.01% | 2836 |
|
|
2023
Q1 | $4.67M | Buy |
271,264
+137,805
| +103% | +$2.37M | ﹤0.01% | 3837 |
|
|
2022
Q4 | $2.69M | Buy |
133,459
+36,065
| +37% | +$726K | ﹤0.01% | 4265 |
|
|
2022
Q3 | $2.11M | Sell |
97,394
-248,345
| -72% | -$5.38M | ﹤0.01% | 4386 |
|
|
2022
Q2 | $9.72M | Buy |
345,739
+167,894
| +94% | +$4.72M | ﹤0.01% | 3095 |
|
|
2022
Q1 | $8.21M | Buy |
177,845
+147,701
| +490% | +$6.81M | ﹤0.01% | 3141 |
|
|
2021
Q4 | $2.53M | Sell |
30,144
-18,087
| -38% | -$1.52M | ﹤0.01% | 4391 |
|
|
2021
Q3 | $3.21M | Sell |
48,231
-20,251
| -30% | -$1.35M | ﹤0.01% | 4160 |
|
|
2021
Q2 | $3.64M | Buy |
68,482
+15,413
| +29% | +$820K | ﹤0.01% | 4111 |
|
|
2021
Q1 | $2.3M | Sell |
53,069
-47,851
| -47% | -$2.08M | ﹤0.01% | 4141 |
|
|
2020
Q4 | $5.24M | Buy |
100,920
+93,346
| +1,232% | +$4.85M | ﹤0.01% | 3210 |
|
|
2020
Q3 | $248K | Sell |
7,574
-2,551
| -25% | -$83.5K | ﹤0.01% | 4996 |
|
|
2020
Q2 | $486K | Buy |
+10,125
| New | +$486K | ﹤0.01% | 4614 |
|